Marex Group’s Pfizer PFE Stock Holding History

Marex Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.93M	Hold	80,000	–	–	0.01%	383
2026 Q1	$2.25M	Buy	+80,000	New	+$2.13M	0.01%	310

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Marex Group's PFE Position: Q2 2026 in Review

Marex Group reduced its Pfizer (PFE) stake by 27% in Q2 2026, selling an estimated $1.73M and leaving 178,990 shares worth $4.31M. The position accounts for 0.02% of the portfolio, ranked #271.

Marex Group first reported a position in PFE in Q4 2023 and has held it in 9 quarters since. The position peaked at $6.88M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Marex Group held 178,990 shares of Pfizer worth $4.31M as of Q2 2026.
Marex Group sold 66,078 Pfizer shares in Q2 2026, an estimated $1.73M.
Pfizer made up 0.02% of Marex Group's portfolio in Q2 2026, its #271 holding.
Marex Group first reported a position in Pfizer in Q4 2023 and has held it in 9 quarters since.
Marex Group's Pfizer position peaked at $6.88M in Q1 2026.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.